Abstract
Abstract Background : The relatively high rate of medication noncompliance in patients with schizophrenia may be in part the result of cognitive impairments frequently associated with the disorder. Objective : The purpose of this study was to determine whether baseline performance on specific neurocognitive tests predicts a patient's level of medication compliance. The question of whether improvement on these same tests after 3 months of antipsychotic treatment would correlate with medication compliance was also examined in this study. Descriptive Correlational Design : Patients' medication compliance (on a percentage basis) was correlated with their baseline and 3-month posttreatment scores on four neurocognitive tests. Results : A statistically significant relationship exists between medication compliance and patients' performance on tests of attention and immediate visual recall. Conclusion : The results of this study support the implementation of interventions that ameliorate specific neurocognitive deficits that, in turn, may facilitate improved medication compliance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of the American Psychiatric Nurses Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.